GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Total Debt per Share

Curocell (XKRX:372320) Total Debt per Share : ₩2,882.63 (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Total Debt per Share?

₩2,882.63 (As of Jun. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Curocell's Total Debt Per Share for the quarter that ended in Jun. 2023 was ₩2,882.63.


Curocell Total Debt per Share Historical Data

The historical data trend for Curocell's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Total Debt per Share Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
5,891.11 535.06 1,118.29 3,059.24 3,152.76

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Total Debt per Share - 3,052.41 2,882.63 3,152.76

Curocell Total Debt per Share Calculation

Curocell's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Curocell's Total Debt Per Share for the quarter that ended in Jun. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curocell Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Curocell's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines